TY - JOUR
T1 - Correction to
T2 - A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (607-618), 10.1007/s00280-020-04135-8)
AU - Kotaka, Masahito
AU - Saito, Yoji
AU - Kato, Takeshi
AU - Satake, Hironaga
AU - Makiyama, Akitaka
AU - Tsuji, Yasushi
AU - Shinozaki, Katsunori
AU - Fujiwara, Toshiyoshi
AU - Mizushima, Tsunekazu
AU - Harihara, Yasushi
AU - Nagata, Naoki
AU - Kurihara, Naoto
AU - Ando, Masahiko
AU - Kusakawa, Genichi
AU - Sakai, Takumi
AU - Uchida, Yugo
AU - Takamoto, Mikihiro
AU - Kimoto, Saki
AU - Hyodo, Ichinosuke
N1 - Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/4
Y1 - 2021/4
N2 - In the Original publication of the article, the authors found an error in the “Results” section under the heading “Abstract”. The corrected text is given below:Seventy-nine participants (placebo n = 28, 1-day ART n = 27, 3-day ART n = 24) received study drugs. The leastsquares mean FACT/GOG-Ntx-12 scores at cycle 12 from the mixed effect model for repeated measures were 28.9 with placebo, 36.3 with 1-day ART [vs. placebo: 7.3 (95% CI 1.9 to 12.8, p = 0.009)], and 32.3 with 3-day ART [vs. placebo: 3.4 (95% CI −2.1 to 9.0, p = 0.222)].
AB - In the Original publication of the article, the authors found an error in the “Results” section under the heading “Abstract”. The corrected text is given below:Seventy-nine participants (placebo n = 28, 1-day ART n = 27, 3-day ART n = 24) received study drugs. The leastsquares mean FACT/GOG-Ntx-12 scores at cycle 12 from the mixed effect model for repeated measures were 28.9 with placebo, 36.3 with 1-day ART [vs. placebo: 7.3 (95% CI 1.9 to 12.8, p = 0.009)], and 32.3 with 3-day ART [vs. placebo: 3.4 (95% CI −2.1 to 9.0, p = 0.222)].
UR - http://www.scopus.com/inward/record.url?scp=85094964611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094964611&partnerID=8YFLogxK
U2 - 10.1007/s00280-020-04185-y
DO - 10.1007/s00280-020-04185-y
M3 - Comment/debate
C2 - 33136172
AN - SCOPUS:85094964611
VL - 87
SP - 585
EP - 586
JO - Cancer Chemotherapy and Pharmacology
JF - Cancer Chemotherapy and Pharmacology
SN - 0344-5704
IS - 4
ER -